TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07796191: A Clinical Trial of Drug-drug Interactions for VC005 Tablets in Healthy Adult Subjects

Sponsor: Jiangsu vcare pharmaceutical technology co., LTD · Phase: PHASE1 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 84 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$7,224,320

Rescue Site Savings

+$4,763,536

Unlock Full NCT07796191 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07796191 Rescue Dossier →